CRIS Current Research Information System

Marconato L, A.M. (2022). A phase 2, single-arm, open-label clinical trial on adjuvant peptide-based anticancer vaccination in dogs with biologically aggressive hemangiosarcoma undergoing surgery and chemotherapy: preliminary results of an ongoing study. Veterinary Cancer Society (VCS).

A phase 2, single-arm, open-label clinical trial on adjuvant peptide-based anticancer vaccination in dogs with biologically aggressive hemangiosarcoma undergoing surgery and chemotherapy: preliminary results of an ongoing study

Marconato L
;Agnoli C;Sabattini S;Foglia A;Del Magno S;Diana A;Romagnoli N;Balboni A;
2022
2022
Veterinary Cancer Society (VCS) 2022 Mid-Year Conference
1
1
Marconato L, A.M. (2022). A phase 2, single-arm, open-label clinical trial on adjuvant peptide-based anticancer vaccination in dogs with biologically aggressive hemangiosarcoma undergoing surgery and chemotherapy: preliminary results of an ongoing study. Veterinary Cancer Society (VCS).
Marconato L, Aralla M, Agnoli C, Melacarne A, Sabattini S, Foglia A, Del Magno S, Diana A, Romagnoli N, Balboni A, Rescigno M.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/913344
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact